Lanraplenib

DESCRIPTION

Lanraplenib (GS-9876) is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.

DETAILS

Cas: 1800046-95-0
Purity: 99.42%
Smiles: N(C=1C=2N(C=C(N1)C3=NC(N)=CN=C3)C=CN2)C4=CC=C(C=C4)N5CCN(CC5)C6COC6
Category: Compound
Molecular Weight: 443.5
Molecular Formula: C23H25N9O

Lead Time: 4 - 5 weeks